Thank you very much.
My understanding, along this same line of thinking, is that in New Zealand you are facing some significant delays when it comes to oncology drugs. You mentioned that there were drugs available in Australia that weren't available at all in New Zealand, and again, this is a detriment to those who need access to these medicines.
My understanding is that this time delay is increasingly detrimental, because what it could do is delay or cut back on the number of clinical trials that are performed within your country with regard to these drugs.
Can you comment on that?